MM

Michael Matly

Managing Partner - 111° West Capital

San Francisco, California

Overview 

Michael Matly is the Co-Founder and Managing Partner of 111° West Capital in San Francisco, with a notable career in investing in various sectors such as Pharmaceuticals, BioTech, and Health IT. Some highlights of his career include leading investments in companies like TigerConnect (Series D) and Pure Life Renal (Series A) while also serving on multiple boards and advisory roles in the healthcare industry.

Work Experience 

  • Co-Founder and Managing Partner

    2021 - Current

  • Investor

    2024

KODE Health is an on-demand medical coding solution for maximum flexibility, quality, and control for systems and Koders alike.

  • Investor

    2022

  • Investor

    2022

Codoxo is an AI-assisted platform for the healthcare sector.

Raised $14,664,991.00 from Spider Capital, Brewer Lane Ventures, Sands Capital Ventures, QED Investors, 111° West Capital and GRA Venture Fund.

  • Investor and Board Member

    2021

Arine optimizes medications and improves human health through data-driven clinical services.

Raised $40,000,000.00 from Katalyst Ventures, New Leaf Venture Partners, MBX Capital, 111° West Capital and Super Capital Group.

  • Venture Advisor

    2022

Rock Health Capital is a full-service seed fund that invests in and supports startups working in digital health.

  • Board Member

    2022 - 2024

  • Investor and Board Member

    2018 - 2022

TigerConnect is a healthcare collaboration platform that streamlines clinical workflows and systems.

Raised $433,900,000.00 from Vista Equity Partners.

  • Investor and Board Member

    2015 - 2021

Tebra provide independent healthcare practices with digital tools and support to thrive in a new era of healthcare.

Raised $137,000,000.00 from StepStone Group, Toba Capital, Golub Capital, Transformation Capital, Common Fund, Vivo Capital, HLM Venture Partners, Montreux Equity Partners and OpenView.

  • Investor and Board Member

    2014 - 2021

Pure Life Renal is a dialysis company enabling nephrologists to manage their standard of care.

Raised $21,000,000.00 from Hamilton Lane, Noro-Moseley Partners and Montreux Equity Partners.

Articles About Michael

Relevant Websites